Mélanie Plazy1,2, Rosemary Dray-Spira3,4, Joanna Orne-Gliemann1,2, François Dabis1,2, Marie-Louise Newell5,6. 1. Centre de recherche Inserm U897 Epidémiologie et Biostatistique, Université Bordeaux, Bordeaux, France. 2. Institut de Santé Publique, d'Epidémiologie et de Développement (ISPED), Université Bordeaux, Bordeaux, France. 3. Epidemiology of Occupational and Social Determinants of Health-Center for Research in Epidemiology and Population Health, Villejuif, France. 4. Université Versailles Saint-Quentin en Yvelines, Villejuif, France. 5. Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Somkhele, South Africa. 6. Faculty of Medicine, University of Southampton, Southampton, UK.
Abstract
OBJECTIVE: To quantify time from entry in HIV care until Antiretroviral therapy (ART) initiation and identify factors associated with ART initiation in rural KwaZulu-Natal, South Africa. METHODS: Adults ≥16 years entering the decentralised Hlabisa ART programme between 2007 and 2011 were followed until June 2013. Median survival times to ART initiation from date of programme entry and from date of ART eligibility were estimated with Kaplan-Meier methods. Associated factors were evaluated in Cox regressions, censoring for deaths. RESULTS: Of 37 749 adults (71.6% female), 17 638 (46.7%) initiated ART. Nearly half (46.9%) met the CD4 criteria for treatment eligibility at programme entry. Among the 20 039 individuals not yet ART-eligible at entry, only 62.5% were retained in care with at least one further CD4 measurement, of whom 6688 subsequently became ART-eligible. Overall, 65.5% of the 24 398 ART-eligible individuals initiated ART over the study period. ART initiation was more likely in women (P < 0.001), in individuals ≥ 25 years old (P < 0.001) and in patients with low CD4 count (P < 0.001). Patients who became eligible during follow up were significantly more likely to initiate ART than those eligible at programme entry (72.6% vs. 62.9%, Adjusted Hazard Ratio = 1.46; 95% Confidence Interval [1.41-1.51]), adjusting for sex, age, year and CD4 count at eligibility. CONCLUSIONS: In this rural programme, continuation of care remains challenging, especially in men and younger adults. ART initiation is more likely in those engaged prior eligibility than in those entering HIV care only late in their HIV disease.
OBJECTIVE: To quantify time from entry in HIV care until Antiretroviral therapy (ART) initiation and identify factors associated with ART initiation in rural KwaZulu-Natal, South Africa. METHODS: Adults ≥16 years entering the decentralised Hlabisa ART programme between 2007 and 2011 were followed until June 2013. Median survival times to ART initiation from date of programme entry and from date of ART eligibility were estimated with Kaplan-Meier methods. Associated factors were evaluated in Cox regressions, censoring for deaths. RESULTS: Of 37 749 adults (71.6% female), 17 638 (46.7%) initiated ART. Nearly half (46.9%) met the CD4 criteria for treatment eligibility at programme entry. Among the 20 039 individuals not yet ART-eligible at entry, only 62.5% were retained in care with at least one further CD4 measurement, of whom 6688 subsequently became ART-eligible. Overall, 65.5% of the 24 398 ART-eligible individuals initiated ART over the study period. ART initiation was more likely in women (P < 0.001), in individuals ≥ 25 years old (P < 0.001) and in patients with low CD4 count (P < 0.001). Patients who became eligible during follow up were significantly more likely to initiate ART than those eligible at programme entry (72.6% vs. 62.9%, Adjusted Hazard Ratio = 1.46; 95% Confidence Interval [1.41-1.51]), adjusting for sex, age, year and CD4 count at eligibility. CONCLUSIONS: In this rural programme, continuation of care remains challenging, especially in men and younger adults. ART initiation is more likely in those engaged prior eligibility than in those entering HIV care only late in their HIV disease.
Keywords:
zzm321990HIVzzm321990; zzm321990VIHzzm321990; Adultos; Afrique du Sud; Antirretrovirales /uso terapéutico; Continuidad de cuidados en el paciente; South Africa; Sudáfrica; adultes; adults; antiretroviral agents/therapeutic use; antirétroviraux; continuity of patient care; continuité des soins aux patients; rural health services; services de santé en milieu rural; servicios sanitarios rurales; usage thérapeutique
Authors: Brendan Maughan-Brown; Caroline Kuo; Omar Galárraga; Philip Smith; Mark N Lurie; Linda-Gail Bekker; Abigail Harrison Journal: AIDS Behav Date: 2018-03
Authors: Ingrid T Katz; Laura M Bogart; Janan J Dietrich; Hannah H Leslie; Hari S Iyer; Dominick Leone; Jessica F Magidson; Valerie A Earnshaw; Ingrid Courtney; Gugu Tshabalala; Garrett M Fitzmaurice; Catherine Orrell; Glenda Gray; David R Bangsberg Journal: AIDS Date: 2019-06-01 Impact factor: 4.177
Authors: Lawrence C Long; Mhairi Maskew; Alana T Brennan; Constance Mongwenyana; Cynthia Nyoni; Given Malete; Ian Sanne; Matthew P Fox; Sydney Rosen Journal: AIDS Date: 2017-07-17 Impact factor: 4.177
Authors: Maria F Nardell; Bethany Hedt-Gauthier; Valerie A Earnshaw; Laura M Bogart; Janan J Dietrich; Ingrid Courtney; Gugulethu Tshabalala; Jacob Bor; Catherine Orrell; Glenda Gray; David R Bangsberg; Ingrid T Katz Journal: AIDS Behav Date: 2021-10-27
Authors: Brendan Maughan-Brown; Sean Beckett; Ayesha B M Kharsany; Cherie Cawood; David Khanyile; Lara Lewis; Atheendar Venkataramani; Gavin George Journal: AIDS Care Date: 2020-02-09
Authors: Catherine Orrell; Kathy Goggin; Ingrid T Katz; Laura M Bogart; Garrett M Fitzmaurice; Vincent S Staggs; Marya V Gwadz; Ingrid V Bassett; Anna Cross; Ingrid Courtney; Lungiswa Tsolekile; Regina Panda; Sonja Steck; David R Bangsberg Journal: AIDS Behav Date: 2020-10-30